Intech Biopharm Corporation (TPEX:6461)
19.15
+1.70 (9.74%)
Jul 11, 2025, 1:07 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 3.12 billion as of July 11, 2025. Its market cap has decreased by -15.89% in one year.
Market Cap
3.12B
Enterprise Value
4.43B
Revenue
32.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.15
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 3.12B, a decrease of -22.08%. That is a compound annual growth rate of -2.24%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Caliway Biopharmaceuticals | 188.45B |
PharmaEssentia | 178.63B |
Bora Pharmaceuticals Co., LTD. | 86.16B |
Lotus Pharmaceutical | 56.28B |
Polaris Group | 29.31B |
Oneness Biotech | 29.27B |
Center Laboratories | 26.92B |
Pegavision | 23.75B |